Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation

Stimulation of iNKT cells by α-galactosyl ceramide (α-GalCer), also known as KRN7000, and its truncated analogue OCH induces both Th1- and Th2-cytokines, with OCH inducing a Th2-cytokine bias. Skewing of the iNKT cells' response towards either a Th1- or Th2-cytokine profile offers potential the...

Full description

Bibliographic Details
Main Authors: Veerapen, N, Reddington, F, Salio, M, Cerundolo, V, Besra, G
Format: Journal article
Language:English
Published: 2011
_version_ 1826281538017296384
author Veerapen, N
Reddington, F
Salio, M
Cerundolo, V
Besra, G
author_facet Veerapen, N
Reddington, F
Salio, M
Cerundolo, V
Besra, G
author_sort Veerapen, N
collection OXFORD
description Stimulation of iNKT cells by α-galactosyl ceramide (α-GalCer), also known as KRN7000, and its truncated analogue OCH induces both Th1- and Th2-cytokines, with OCH inducing a Th2-cytokine bias. Skewing of the iNKT cells' response towards either a Th1- or Th2-cytokine profile offers potential therapeutic benefits. The length of both the acyl and the sphingosine chains in α-galactosyl ceramides is known to influence the cytokine release profile. We have synthesized analogues of α-GalCer with truncated sphingosine chains for biological evaluation, with particular emphasis on the Th1/Th2 distribution. Starting from a common precursor, d-lyxose, the sphingosine derivatives were synthesised via a straightforward Wittig condensation. © 2010 Elsevier Ltd. All rights reserved.
first_indexed 2024-03-07T00:30:18Z
format Journal article
id oxford-uuid:7f8c8d4a-1ae4-4c63-ac97-91eceffdc3ec
institution University of Oxford
language English
last_indexed 2024-03-07T00:30:18Z
publishDate 2011
record_format dspace
spelling oxford-uuid:7f8c8d4a-1ae4-4c63-ac97-91eceffdc3ec2022-03-26T21:17:40ZSynthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7f8c8d4a-1ae4-4c63-ac97-91eceffdc3ecEnglishSymplectic Elements at Oxford2011Veerapen, NReddington, FSalio, MCerundolo, VBesra, GStimulation of iNKT cells by α-galactosyl ceramide (α-GalCer), also known as KRN7000, and its truncated analogue OCH induces both Th1- and Th2-cytokines, with OCH inducing a Th2-cytokine bias. Skewing of the iNKT cells' response towards either a Th1- or Th2-cytokine profile offers potential therapeutic benefits. The length of both the acyl and the sphingosine chains in α-galactosyl ceramides is known to influence the cytokine release profile. We have synthesized analogues of α-GalCer with truncated sphingosine chains for biological evaluation, with particular emphasis on the Th1/Th2 distribution. Starting from a common precursor, d-lyxose, the sphingosine derivatives were synthesised via a straightforward Wittig condensation. © 2010 Elsevier Ltd. All rights reserved.
spellingShingle Veerapen, N
Reddington, F
Salio, M
Cerundolo, V
Besra, G
Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
title Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
title_full Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
title_fullStr Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
title_full_unstemmed Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
title_short Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
title_sort synthesis of truncated analogues of the inkt cell agonist α galactosyl ceramide krn7000 and their biological evaluation
work_keys_str_mv AT veerapenn synthesisoftruncatedanaloguesoftheinktcellagonistagalactosylceramidekrn7000andtheirbiologicalevaluation
AT reddingtonf synthesisoftruncatedanaloguesoftheinktcellagonistagalactosylceramidekrn7000andtheirbiologicalevaluation
AT saliom synthesisoftruncatedanaloguesoftheinktcellagonistagalactosylceramidekrn7000andtheirbiologicalevaluation
AT cerundolov synthesisoftruncatedanaloguesoftheinktcellagonistagalactosylceramidekrn7000andtheirbiologicalevaluation
AT besrag synthesisoftruncatedanaloguesoftheinktcellagonistagalactosylceramidekrn7000andtheirbiologicalevaluation